蘑菇传媒

A University team found a way to make chemotherapy more effective by exposing cancer cells to a molecule that inhibits NMD (nonsense-mediated mRNA decay) prior to treatment with doxorubicin, a drug used to treat leukemia, breast, bone, lung and other cancers.

The National Institutes of Health has invited the Medical Center to join the NIH Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus Network. Made up of 11 research groups from around the country, its aim is to develop new treatments for patients with the conditions.

鈥淭argeting the Inflammatory Pathways 2012,鈥� a conference sponsored by the Center for Experiential Learning, will be held from 7:45 a.m. to 3:30 p.m. Saturday, Sept. 29, at the Saunders Research Building.